Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zeinab Bidel

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
The Lancet. Oncology|April 1, 2021
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysisEmma Copland, Dexter Canoy, Milad Nazarzadeh, et al.
Journal of Religion and Health|October 24, 2018
Religion, Spirituality and Risk of Coronary Heart Disease: A Matched Case-Control Study and Meta-AnalysisRohoullah Hemmati, Zeinab Bidel, Milad Nazarzadeh, et al.
Nature Medicine|July 1, 2026
A meta-analysis of the long-term effects of antihypertensive therapy on the risk of major cardiovascular disease across 51 randomized trialsQianqian Yang, Zeinab Bidel, Dexter Canoy, et al.
Lancet (London, England)|April 26, 2026
Pharmacological blood-pressure lowering for the prevention of cardiovascular disease and death across the full spectrum of chronic kidney disease severity: an individual-participant data meta-analysisGuyu Zeng, Zeinab Bidel, Qianqian Yang, et al.
The Lancet. Healthy Longevity|February 11, 2024
Efficacy of decentralised home-based antihypertensive treatment in older adults with multimorbidity and polypharmacy (ATEMPT): an open-label randomised controlled pilot trialJeannette Majert, Milad Nazarzadeh, Rema Ramakrishnan, et al.
Hypertension (Dallas, Tex. : 1979)|July 24, 2023
Sex-Specific Effects of Blood Pressure Lowering Pharmacotherapy for the Prevention of Cardiovascular Disease: An Individual Participant-Level Data Meta-AnalysisZeinab Bidel, Milad Nazarzadeh, Dexter Canoy, et al.
Lancet (London, England)|November 14, 2021
Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysisMilad Nazarzadeh, Zeinab Bidel, Dexter Canoy, et al.
BMJ Open|April 2, 2026
First population-based study on non-communicable diseases and risk factors in northeastern Iran: Sabzevar cohort profileFereshteh Ghorat, Reza Chaman, Seyed Alireza Javadinia, et al.
JACC. Cardiooncology|May 14, 2025
Blood Pressure Lowering and Risk of Cancer: Individual Participant-Level Data Meta-Analysis and Mendelian Randomization StudiesMilad Nazarzadeh, Emma Copland, Karl Smith Byrne, et al.
The Lancet. Diabetes & Endocrinology|July 25, 2022
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysisMilad Nazarzadeh, Zeinab Bidel, Dexter Canoy, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
The Lancet. Oncology|April 1, 2021
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysisEmma Copland, Dexter Canoy, Milad Nazarzadeh, et al.
Journal of Religion and Health|October 24, 2018
Religion, Spirituality and Risk of Coronary Heart Disease: A Matched Case-Control Study and Meta-AnalysisRohoullah Hemmati, Zeinab Bidel, Milad Nazarzadeh, et al.
Nature Medicine|July 1, 2026
A meta-analysis of the long-term effects of antihypertensive therapy on the risk of major cardiovascular disease across 51 randomized trialsQianqian Yang, Zeinab Bidel, Dexter Canoy, et al.
Lancet (London, England)|April 26, 2026
Pharmacological blood-pressure lowering for the prevention of cardiovascular disease and death across the full spectrum of chronic kidney disease severity: an individual-participant data meta-analysisGuyu Zeng, Zeinab Bidel, Qianqian Yang, et al.
The Lancet. Healthy Longevity|February 11, 2024
Efficacy of decentralised home-based antihypertensive treatment in older adults with multimorbidity and polypharmacy (ATEMPT): an open-label randomised controlled pilot trialJeannette Majert, Milad Nazarzadeh, Rema Ramakrishnan, et al.
Hypertension (Dallas, Tex. : 1979)|July 24, 2023
Sex-Specific Effects of Blood Pressure Lowering Pharmacotherapy for the Prevention of Cardiovascular Disease: An Individual Participant-Level Data Meta-AnalysisZeinab Bidel, Milad Nazarzadeh, Dexter Canoy, et al.
Lancet (London, England)|November 14, 2021
Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysisMilad Nazarzadeh, Zeinab Bidel, Dexter Canoy, et al.
BMJ Open|April 2, 2026
First population-based study on non-communicable diseases and risk factors in northeastern Iran: Sabzevar cohort profileFereshteh Ghorat, Reza Chaman, Seyed Alireza Javadinia, et al.
JACC. Cardiooncology|May 14, 2025
Blood Pressure Lowering and Risk of Cancer: Individual Participant-Level Data Meta-Analysis and Mendelian Randomization StudiesMilad Nazarzadeh, Emma Copland, Karl Smith Byrne, et al.
The Lancet. Diabetes & Endocrinology|July 25, 2022
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysisMilad Nazarzadeh, Zeinab Bidel, Dexter Canoy, et al.
Pageof 3